Schulga A - Search Results

1

Accessing Mitochondrial Protein Import in Living Cells by Protein Microinjection.

Bogorodskiy A, Okhrimenko I, Maslov I, Maliar N, Burkatovskii D, von Ameln F, Schulga A, Jakobs P, Altschmied J, Haendeler J, Katranidis A, Sorokin I, Mishin A, Gordeliy V, Büldt G, Voos W, Gensch T, Borshchevskiy V. Bogorodskiy A, et al. Among authors: schulga a. Front Cell Dev Biol. 2021 Jul 7;9:698658. doi: 10.3389/fcell.2021.698658. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34307376 Free PMC article.

2

Effect of Surface Modification of Multifunctional Nanocomposite Drug Delivery Carriers with DARPin on Their Biodistribution In Vitro and In Vivo.

Novoselova M, Chernyshev VS, Schulga A, Konovalova EV, Chuprov-Netochin RN, Abakumova TO, German S, Shipunova VO, Mokrousov MD, Prikhozhdenko E, Bratashov DN, Nozdriukhin DV, Bogorodskiy A, Grishin O, Kosolobov SS, Khlebtsov BN, Inozemtseva O, Zatsepin TS, Deyev SM, Gorin DA. Novoselova M, et al. Among authors: schulga a. ACS Appl Bio Mater. 2022 Jun 20;5(6):2976-2989. doi: 10.1021/acsabm.2c00289. Epub 2022 May 26. ACS Appl Bio Mater. 2022. PMID: 35616387

3

Loop 3 of short neurotoxin II is an additional interaction site with membrane-bound nicotinic acetylcholine receptor as detected by solid-state NMR spectroscopy.

Krabben L, van Rossum BJ, Jehle S, Bocharov E, Lyukmanova EN, Schulga AA, Arseniev A, Hucho F, Oschkinat H. Krabben L, et al. Among authors: schulga aa. J Mol Biol. 2009 Jul 24;390(4):662-71. doi: 10.1016/j.jmb.2009.05.016. Epub 2009 May 15. J Mol Biol. 2009. PMID: 19447114

4

Targeted Delivery of HSP70 to Tumor Cells via Supramolecular Complex Based on HER2-Specific DARPin9_29 and the Barnase:Barstar Pair.

Alekseeva LG, Ovsyanikova OV, Schulga AA, Grechikhina MV, Shustova OA, Kovalenko EI, Svirshchevskaya EV, Deyev SM, Sapozhnikov AM. Alekseeva LG, et al. Among authors: schulga aa. Cells. 2024 Feb 9;13(4):317. doi: 10.3390/cells13040317. Cells. 2024. PMID: 38391930 Free PMC article.

5

Recombinant targeted toxin based on HER2-specific DARPin possesses a strong selective cytotoxic effect in vitro and a potent antitumor activity in vivo.

Sokolova E, Proshkina G, Kutova O, Shilova O, Ryabova A, Schulga A, Stremovskiy O, Zdobnova T, Balalaeva I, Deyev S. Sokolova E, et al. Among authors: schulga a. J Control Release. 2016 Jul 10;233:48-56. doi: 10.1016/j.jconrel.2016.05.020. Epub 2016 May 10. J Control Release. 2016. PMID: 27178808

6

Data on characterization of magnetic nanoparticles stabilized with fusion protein of Barstar and C-term part of Mms6.

Shipunova VO, Kotelnikova PA, Aghayeva UF, Stremovskiy OA, Schulga AA, Nikitin MP, Deyev SM. Shipunova VO, et al. Among authors: schulga aa. Data Brief. 2018 Nov 3;21:1659-1663. doi: 10.1016/j.dib.2018.10.173. eCollection 2018 Dec. Data Brief. 2018. PMID: 30505896 Free PMC article.

7

Comparative Evaluation of Two DARPin Variants: Effect of Affinity, Size, and Label on Tumor Targeting Properties.

Deyev S, Vorobyeva A, Schulga A, Proshkina G, Güler R, Löfblom J, Mitran B, Garousi J, Altai M, Buijs J, Chernov V, Orlova A, Tolmachev V. Deyev S, et al. Among authors: schulga a. Mol Pharm. 2019 Mar 4;16(3):995-1008. doi: 10.1021/acs.molpharmaceut.8b00922. Epub 2019 Feb 8. Mol Pharm. 2019. PMID: 30608701

8

Penetration Efficiency of Antitumor Agents in Ovarian Cancer Spheroids: The Case of Recombinant Targeted Toxin DARPin-LoPE and the Chemotherapy Drug, Doxorubicin.

Sokolova E, Kutova O, Grishina A, Pospelov A, Guryev E, Schulga A, Deyev S, Balalaeva I. Sokolova E, et al. Among authors: schulga a. Pharmaceutics. 2019 May 7;11(5):219. doi: 10.3390/pharmaceutics11050219. Pharmaceutics. 2019. PMID: 31067739 Free PMC article.

9

HER2-Specific Targeted Toxin DARPin-LoPE: Immunogenicity and Antitumor Effect on Intraperitoneal Ovarian Cancer Xenograft Model.

Sokolova EA, Shilova ON, Kiseleva DV, Schulga AA, Balalaeva IV, Deyev SM. Sokolova EA, et al. Among authors: schulga aa. Int J Mol Sci. 2019 May 15;20(10):2399. doi: 10.3390/ijms20102399. Int J Mol Sci. 2019. PMID: 31096563 Free PMC article.

10

Indirect Radioiodination of DARPin G3 Using N-succinimidyl-Para-Iodobenzoate Improves the Contrast of HER2 Molecular Imaging.

Vorobyeva A, Schulga A, Rinne SS, Günther T, Orlova A, Deyev S, Tolmachev V. Vorobyeva A, et al. Among authors: schulga a. Int J Mol Sci. 2019 Jun 21;20(12):3047. doi: 10.3390/ijms20123047. Int J Mol Sci. 2019. PMID: 31234471 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

61 results

Search Page